Drug intelligence / Profile preview

ambroxol hydrochloride + glucose injection

Development stage
Unknown
Lead developer
Hebei Aierhaitai Pharmaceutical
Modality
Small Molecules
Administration
Intravenous
01

Overview

Ambroxol hydrochloride + glucose injection is a mucolytic and expectorant formulation developed by Hebei Aier Haitai Technology. The active ingredient, ambroxol hydrochloride, is a secretolytic agent used in the treatment of respiratory diseases associated with viscid or excessive mucus. It works by increasing the production of pulmonary surfactant, stimulating ciliary activity, and reducing mucus viscosity, thereby facilitating expectoration and easing cough. The glucose component serves as an isotonic vehicle for intravenous administration. This formulation is approved in China for indications including acute and chronic bronchitis, bronchial asthma, and the prevention of postoperative pulmonary complications.

Other names
盐酸氨溴索葡萄糖注射液Ambroxol Hydrochloride and Glucose InjectionAmbroxol Hydrochloride & Glucose Injection
02

Targets

sGC (Soluble Guanylyl Cyclase)GBA1 (Glucosylceramidase)SCN10A (Sodium channel protein type X alpha subunit)

Beyond the preview

Go deeper on ambroxol hydrochloride + glucose injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ambroxol hydrochloride + glucose injection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call